Sight Sciences, Inc.(SGHT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

SGHT Sight Sciences, Inc.

Pre-Mkt 12-19 08:07:46 EST

8.26

+0.11

+1.35%

High8.64	Low8.13	Vol207.86K
Open8.39	D1 Closing8.15	Amplitude6.26%
Mkt Cap436.72M	Tradable Cap238.05M	Total Shares52.87M
T/O1.72M	T/O Rate0.72%	Tradable Shares28.82M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"SGHT","market":"US","secType":"STK","nameCN":"Sight Sciences, Inc.","latestPrice":8.26,"timestamp":1766091600000,"preClose":8.15,"halted":0,"volume":207862,"delay":0,"floatShares":28819045,"shares":52871731,"eps":-0.894022,"marketStatus":"Pre-Mkt","change":0.11,"latestTime":"12-19 08:07:46 EST","open":8.39,"high":8.64,"low":8.13,"amount":1722400.239016,"amplitude":0.062577,"askPrice":9.35,"askSize":100,"bidPrice":7.57,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.894022,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1766154600000},"marketStatusCode":1,"adr":0,"listingDate":1626321600000,"exchange":"NASDAQ","adjPreClose":8.26,"postHourTrading":{"tag":"盘后","latestPrice":8.42,"preClose":8.26,"latestTime":"19:28 EST","volume":10790,"amount":90734.82,"timestamp":1766104115797},"volumeRatio":0.8422145659964987,"impliedVol":1.5142,"impliedVolPercentile":0.5663},"requestUrl":"/m/hq/s/SGHT/tweets","defaultTab":"tweets","newsList":[{"id":"2592187748","title":"Director Staffan Encrantz Reports Acquisition of Sight Sciences Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2592187748","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592187748?lang=en_us&edition=fundamental","pubTime":"2025-12-19 07:10","pubTimestamp":1766099442,"startTime":"0","endTime":"0","summary":"Staffan Encrantz, Director and 10% Owner of Sight Sciences Inc., reported an acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sight Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 18, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nNDLbtGncK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Director Staffan Encrantz Reports Acquisition of Sight Sciences Inc. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGHT","BK4539","BK4082"],"gpt_icon":0},{"id":"2590549720","title":"Sight Sciences Is Maintained at Neutral by Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2590549720","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590549720?lang=en_us&edition=fundamental","pubTime":"2025-12-12 05:15","pubTimestamp":1765487700,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SGHT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 11, 2025 16:15 ET (21:15 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGHT"],"gpt_icon":0},{"id":"2590532019","title":"Sight Sciences Is Maintained at Buy by Lake Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2590532019","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590532019?lang=en_us&edition=fundamental","pubTime":"2025-12-11 03:10","pubTimestamp":1765393800,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SGHT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 10, 2025 14:10 ET (19:10 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGHT"],"gpt_icon":0},{"id":"2584926024","title":"Sight Sciences Q3 Revenue USD 19.9 Million Vs. IBES Estimate USD 17.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2584926024","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584926024?lang=en_us&edition=fundamental","pubTime":"2025-11-20 00:58","pubTimestamp":1763571510,"startTime":"0","endTime":"0","summary":"Nov 06 (Reuters) - Sight Sciences Q3 operating expenses USD 25.1 million.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 06-NOV-202521:05:55.43 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD8nYxp0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4539","SGHT"],"gpt_icon":0},{"id":"2582667333","title":"New Peer-Reviewed Publications Highlight Effectiveness of OMNI® Surgical System with TruSync™ Technology in Reducing IOP and Medication Usage in Cataract Combination Procedures, Standalone Procedures, and in African Americans","url":"https://stock-news.laohu8.com/highlight/detail?id=2582667333","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582667333?lang=en_us&edition=fundamental","pubTime":"2025-11-11 20:00","pubTimestamp":1762862400,"startTime":"0","endTime":"0","summary":"Prospective study data and retrospective registry data were analyzed in the manuscripts recently published by the Journal of Cataract and Refractive Surgery, Journal of Glaucoma and Clinical Ophthalmo","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/11/3185297/0/en/New-Peer-Reviewed-Publications-Highlight-Effectiveness-of-OMNI-Surgical-System-with-TruSync-Technology-in-Reducing-IOP-and-Medication-Usage-in-Cataract-Combination-Procedures-Stand.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","SGHT","BK4539"],"gpt_icon":0},{"id":"2581514888","title":"Sight Sciences Is Maintained at Neutral by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2581514888","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581514888?lang=en_us&edition=fundamental","pubTime":"2025-11-07 20:57","pubTimestamp":1762520220,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SGHT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 07, 2025 07:57 ET (12:57 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGHT"],"gpt_icon":0},{"id":"2581604002","title":"Sight Sciences price target raised to $5 from $4 at Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2581604002","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581604002?lang=en_us&edition=fundamental","pubTime":"2025-11-07 19:56","pubTimestamp":1762516587,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst Matt O’Brien raised the firm’s price target on Sight Sciences (SGHT) to $5 from $4 and keeps a Neutral rating on the shares. ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sight-sciences-price-target-raised-to-5-from-4-at-piper-sandler-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sight-sciences-price-target-raised-to-5-from-4-at-piper-sandler-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SGHT"],"gpt_icon":0},{"id":"2581477006","title":"Balanced Outlook: Hold Rating on Sight Sciences Amid Strong Performance and Uncertainties","url":"https://stock-news.laohu8.com/highlight/detail?id=2581477006","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581477006?lang=en_us&edition=fundamental","pubTime":"2025-11-07 18:26","pubTimestamp":1762511179,"startTime":"0","endTime":"0","summary":"Needham analyst David Saxon has maintained their neutral stance on SGHT stock, giving a Hold rating on October 22. David Saxon has given his Hold r...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/balanced-outlook-hold-rating-on-sight-sciences-amid-strong-performance-and-uncertainties-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/balanced-outlook-hold-rating-on-sight-sciences-amid-strong-performance-and-uncertainties-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SGHT"],"gpt_icon":0},{"id":"2581272980","title":"Sight Sciences Raises Revenue Guidance Amid Strategic Shifts","url":"https://stock-news.laohu8.com/highlight/detail?id=2581272980","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581272980?lang=en_us&edition=fundamental","pubTime":"2025-11-07 13:16","pubTimestamp":1762492613,"startTime":"0","endTime":"0","summary":"Sight Sciences, Inc. ( ($SGHT) ) has released its Q3 earnings. Here is a breakdown of the information Sight Sciences, Inc. presented to its investo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sight-sciences-raises-revenue-guidance-amid-strategic-shifts?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sight-sciences-raises-revenue-guidance-amid-strategic-shifts?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SGHT"],"gpt_icon":0},{"id":"2581241850","title":"Sight Sciences Inc : Piper Sandler Raises Target Price to $5 From $4","url":"https://stock-news.laohu8.com/highlight/detail?id=2581241850","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581241850?lang=en_us&edition=fundamental","pubTime":"2025-11-07 12:08","pubTimestamp":1762488494,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nFWN3WI2VG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","SGHT","BK4082"],"gpt_icon":0},{"id":"2581080049","title":"BRIEF-Sight Sciences Inc -  Has Exposure To Tariffs Imposed By The U.S. On China Because Most Of Its Products Are Produced And Assembled In China","url":"https://stock-news.laohu8.com/highlight/detail?id=2581080049","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581080049?lang=en_us&edition=fundamental","pubTime":"2025-11-07 06:37","pubTimestamp":1762468649,"startTime":"0","endTime":"0","summary":"BRIEF-Sight Sciences Inc -  Has Exposure To Tariffs Imposed By The U.S. On China Because Most Of Its Products Are Produced And Assembled In ChinaNov 7  - Sight Sciences Inc SGHT.O:SIGHT SCIENCES INC -  HAS EXPOSURE TO TARIFFS IMPOSED BY THE U.S. ON CHINA BECAUSE MOST OF ITS PRODUCTS ARE PRODUCED AND ASSEMBLED IN CHINASIGHT SCIENCES- EXPECT SURGICAL GLAUCOMA SEGMENT’S TARIFF EXPOSURE TO INCREASE SEGMENT’S COST OF GOODS SOLD BY BETWEEN $1.0 MILLION - $1.5 MILLION FOR 2025Source text: [ID:n0001193125-25-269525]Further company coverage: SGHT.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nFWN3WI2AU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4539","SGHT"],"gpt_icon":0},{"id":"2581466540","title":"Sight Sciences Q3 revenue beats expectations, raises 2025 guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2581466540","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581466540?lang=en_us&edition=fundamental","pubTime":"2025-11-07 06:03","pubTimestamp":1762466599,"startTime":"0","endTime":"0","summary":"Sight Sciences Q3 revenue beats expectations, raises 2025 guidanceOverviewSight Sciences Q3 2025 revenue beats analyst expectations despite a 1% yr/yr declineCompany raises full-year 2025 revenue guid","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nL1N3WI1LS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4082","SGHT"],"gpt_icon":0},{"id":"2581045492","title":"Sight Sciences Inc -  Has Exposure to Tariffs Imposed by the U.S. on China Because Most of Its Products Are Produced and Assembled in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2581045492","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581045492?lang=en_us&edition=fundamental","pubTime":"2025-11-07 05:52","pubTimestamp":1762465970,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nFWN3WI2AU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4082","SGHT"],"gpt_icon":0},{"id":"2581045470","title":"Sight Sciences- Expect Surgical Glaucoma Segment’s Tariff Exposure to Increase Segment’s Cost of Goods Sold by Between $1.0 Mln - $1.5 Mln for 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2581045470","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581045470?lang=en_us&edition=fundamental","pubTime":"2025-11-07 05:52","pubTimestamp":1762465970,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nFWN3WI2AU:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SGHT","BK4082","BK4539"],"gpt_icon":0},{"id":"2581104329","title":"Sight Sciences Inc. Files Initial Beneficial Ownership Statement for Chief Financial Officer James Rodberg","url":"https://stock-news.laohu8.com/highlight/detail?id=2581104329","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581104329?lang=en_us&edition=fundamental","pubTime":"2025-11-07 05:37","pubTimestamp":1762465076,"startTime":"0","endTime":"0","summary":"Sight Sciences Inc. has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission. The filing lists James Rodberg, Chief Financial Officer, as the beneficial owner. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sight Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 06, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDL30bz45:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","SGHT","BK4539"],"gpt_icon":0},{"id":"2581048771","title":"Sight Sciences Q3 Revenue USD 19.9 Million Vs. IBES Estimate USD 17.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2581048771","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581048771?lang=en_us&edition=fundamental","pubTime":"2025-11-07 05:26","pubTimestamp":1762464417,"startTime":"0","endTime":"0","summary":"Nov 06 (Reuters) - Sight Sciences Q3 operating expenses USD 25.1 million.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 06-NOV-202521:05:55.43 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nRSD8nYxp0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4082","SGHT"],"gpt_icon":0},{"id":"2581787048","title":"Sight Sciences posts Q3 net loss of $8.2 million on $19.9 million revenue and raises 2025 guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2581787048","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581787048?lang=en_us&edition=fundamental","pubTime":"2025-11-07 05:24","pubTimestamp":1762464249,"startTime":"0","endTime":"0","summary":"Sight Sciences Inc. reported third quarter 2025 total revenue of $19.9 million, a decrease of 1.0% compared to the same period in the prior year. The company's Surgical Glaucoma revenue increased 6.0%, while revenue from the Dry Eye segment declined 88.0% compared to the third quarter of 2024, due to a continued focus on achieving reimbursed market access. Net loss for the quarter was $8.2 million, or $0.16 per share, compared to a net loss of $11.1 million, or $0.22 per share, in the prior year period. Total operating expenses were reduced to $25.1 million, down 11.0% year-over-year, including $2.8 million in restructuring costs. Sight Sciences raised its full year 2025 revenue guidance to $76.0 million to $78.0 million, now expecting a 2.0% to 5.0% decline compared to 2024 revenue. Cash and cash equivalents totaled $92.4 million as of September 30, 2025.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDL1Fnfd4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","SGHT","BK4539"],"gpt_icon":0},{"id":"2581104549","title":"Sight Sciences Q3 EPS USD -0.16","url":"https://stock-news.laohu8.com/highlight/detail?id=2581104549","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581104549?lang=en_us&edition=fundamental","pubTime":"2025-11-07 05:05","pubTimestamp":1762463111,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nPLX3710DD:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","SGHT","BK4082"],"gpt_icon":0},{"id":"2581343045","title":"Sight Sciences Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Revenue Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2581343045","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581343045?lang=en_us&edition=fundamental","pubTime":"2025-11-07 05:05","pubTimestamp":1762463100,"startTime":"0","endTime":"0","summary":"MENLO PARK, Calif., Nov.  06, 2025  (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing inn","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/06/3183087/0/en/Sight-Sciences-Reports-Third-Quarter-2025-Financial-Results-and-Raises-Full-Year-2025-Revenue-Guidance.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGHT"],"gpt_icon":0},{"id":"2581017989","title":"Press Release: Sight Sciences Appoints Ali Bauerlein as Chief Operating Officer and Jim Rodberg as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2581017989","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581017989?lang=en_us&edition=fundamental","pubTime":"2025-11-07 05:04","pubTimestamp":1762463040,"startTime":"0","endTime":"0","summary":"MENLO PARK, Calif., Nov. 06, 2025  -- Sight Sciences, Inc.  , an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, announced today the appointment of Alison  Bauerlein as its Chief Operating Officer  and James  Rodberg as its Chief Financial Officer , effective November 5, 2025.Erica Rogers and Brenda Becker have stepped down from the Sight Sciences Board of Directors. \"I would like to thank both Erica and Brenda for their contributions to our vision and mission over the last six and three years, respectively. Erica's high-growth medtech leadership experience was invaluable as we scaled our business from early commercialization, and Brenda's decades of public service and private sector expertise helped support","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Press Release: Sight Sciences Appoints Ali Bauerlein as Chief Operating Officer and Jim Rodberg as Chief Financial Officer","news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGHT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sightsciences.com","stockEarnings":[{"period":"1week","weight":-0.0024},{"period":"1month","weight":0.1569},{"period":"3month","weight":1.2944},{"period":"6month","weight":1.0345},{"period":"1year","weight":1.4223},{"period":"ytd","weight":1.2692}],"compareEarnings":[{"period":"1week","weight":-0.0184},{"period":"1month","weight":0.0248},{"period":"3month","weight":0.0192},{"period":"6month","weight":0.1383},{"period":"1year","weight":0.1538},{"period":"ytd","weight":0.1542}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.158431},{"month":2,"riseRate":0.25,"avgChangeRate":0.009629},{"month":3,"riseRate":0.25,"avgChangeRate":-0.080232},{"month":4,"riseRate":0.75,"avgChangeRate":0.008045},{"month":5,"riseRate":0.75,"avgChangeRate":0.153551},{"month":6,"riseRate":0.75,"avgChangeRate":0.011494},{"month":7,"riseRate":0.75,"avgChangeRate":0.016943},{"month":8,"riseRate":0.2,"avgChangeRate":-0.12923},{"month":9,"riseRate":0,"avgChangeRate":-0.199558},{"month":10,"riseRate":0.6,"avgChangeRate":0.031217},{"month":11,"riseRate":0.6,"avgChangeRate":0.36099},{"month":12,"riseRate":0.4,"avgChangeRate":0.069057}],"exchange":"NASDAQ","name":"Sight Sciences, Inc.","nameEN":"Sight Sciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Sight Sciences, Inc.(SGHT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Sight Sciences, Inc.(SGHT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Sight Sciences, Inc.,SGHT,Sight Sciences, Inc.股票,Sight Sciences, Inc.股票老虎,Sight Sciences, Inc.股票老虎国际,Sight Sciences, Inc.行情,Sight Sciences, Inc.股票行情,Sight Sciences, Inc.股价,Sight Sciences, Inc.股市,Sight Sciences, Inc.股票价格,Sight Sciences, Inc.股票交易,Sight Sciences, Inc.股票购买,Sight Sciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Sight Sciences, Inc.(SGHT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Sight Sciences, Inc.(SGHT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction